2018 – NovAccess Global

Innovest Global Provides December Shareholder Update Featuring Acquisition Update, Revenue Growth, Biotech Progress

Innovest Global Biotech Partners with Preeminent Los Angeles Association

Innovest Global Announces Elite Biotech Team

Innovest Global Biotech Division Sets Fall Conference Schedule

Innovest Global Biotech Division Sets Fall Conference Schedule

Innovest Global Provides August Shareholder Update with Milestones Including Patent Approval, Biotech Progress, Financial Achievements

Innovest Global Provides August Shareholder Update with Milestones Including Patent Approval, Biotech Progress, Financial Achievements

StemVax Obtains the Exclusive Worldwide Rights to Four Key Technologies

Innovest Global Announces Patent is Approved for StemVax Therapeutics

Innovest Global Acquires Stake in StemVax Therapeutics| Innovest Global

Revolutionary advances in the understanding of how our bodies can fight cancer, and how to put that information to use in treating existing tumors. NovAccess Global’s team of experts is working to strengthen the capability of the human body’s defense against cancer.

Forward-Looking Statements

Contact Us

JOIN US

Stay up-to-date with our journey

Privacy Policy

Privacy Policy

Forward-Looking Statements